Diarrhea as a Potential Cause and Consequence of Reduced Gut Microbial Diversity Among Undernourished Children in Peru.
diarrhea
microbiota
stunting
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
14 08 2020
14 08 2020
Historique:
received:
16
03
2019
accepted:
13
09
2019
pubmed:
28
11
2019
medline:
28
4
2021
entrez:
28
11
2019
Statut:
ppublish
Résumé
Detrimental effects of diarrhea on child growth and survival are well documented, but details of the underlying mechanisms remain poorly understood. Recent evidence demonstrates that perturbations to normal development of the gut microbiota in early life may contribute to growth faltering and susceptibility to related childhood diseases. We assessed associations between diarrhea, gut microbiota configuration, and childhood growth in the Peruvian Amazon. Growth, diarrhea incidence, illness, pathogen infection, and antibiotic exposure were assessed monthly in a birth cohort of 271 children aged 0-24 months. Gut bacterial diversity and abundances of specific bacterial taxa were quantified by sequencing 16S rRNA genes in fecal samples collected at 6, 12, 18, and 24 months. Linear and generalized linear models were used to determine whether diarrhea was associated with altered microbiota and, in turn, if features of the microbiota were associated with the subsequent risk of diarrhea. Diarrheal frequency, duration, and severity were negatively associated with bacterial diversity and richness (P < .05). Children born stunted (length-for-age z-score [LAZ] ≤ -2) who were also severely stunted (LAZ ≤ -3) at the time of sampling exhibited the greatest degree of diarrhea-associated reductions in bacterial diversity and the slowest recovery of bacterial diversity after episodes of diarrhea. Increased bacterial diversity was predictive of reduced subsequent diarrhea from age 6 to 18 months. Persistent, severe growth faltering may reduce the gut microbiota's resistance and resilience to diarrhea, leading to greater losses of diversity and longer recovery times. This phenotype, in turn, denotes an increased risk of future diarrheal disease and growth faltering.
Sections du résumé
BACKGROUND
Detrimental effects of diarrhea on child growth and survival are well documented, but details of the underlying mechanisms remain poorly understood. Recent evidence demonstrates that perturbations to normal development of the gut microbiota in early life may contribute to growth faltering and susceptibility to related childhood diseases. We assessed associations between diarrhea, gut microbiota configuration, and childhood growth in the Peruvian Amazon.
METHODS
Growth, diarrhea incidence, illness, pathogen infection, and antibiotic exposure were assessed monthly in a birth cohort of 271 children aged 0-24 months. Gut bacterial diversity and abundances of specific bacterial taxa were quantified by sequencing 16S rRNA genes in fecal samples collected at 6, 12, 18, and 24 months. Linear and generalized linear models were used to determine whether diarrhea was associated with altered microbiota and, in turn, if features of the microbiota were associated with the subsequent risk of diarrhea.
RESULTS
Diarrheal frequency, duration, and severity were negatively associated with bacterial diversity and richness (P < .05). Children born stunted (length-for-age z-score [LAZ] ≤ -2) who were also severely stunted (LAZ ≤ -3) at the time of sampling exhibited the greatest degree of diarrhea-associated reductions in bacterial diversity and the slowest recovery of bacterial diversity after episodes of diarrhea. Increased bacterial diversity was predictive of reduced subsequent diarrhea from age 6 to 18 months.
CONCLUSIONS
Persistent, severe growth faltering may reduce the gut microbiota's resistance and resilience to diarrhea, leading to greater losses of diversity and longer recovery times. This phenotype, in turn, denotes an increased risk of future diarrheal disease and growth faltering.
Identifiants
pubmed: 31773127
pii: 5571185
doi: 10.1093/cid/ciz905
pmc: PMC7053391
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
989-999Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK056341
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S248-54
pubmed: 25305294
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Science. 2016 Feb 19;351(6275):
pubmed: 26912898
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
Nat Commun. 2019 Mar 12;10(1):1092
pubmed: 30862783
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S225-32
pubmed: 25305291
Trop Dis Travel Med Vaccines. 2016 Jul 19;2:11
pubmed: 28883955
Am J Clin Nutr. 1972 Nov;25(11):1267-75
pubmed: 5086049
Lancet Glob Health. 2017 Dec;5(12):e1168-e1169
pubmed: 29132605
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Bioinformatics. 2010 Jun 1;26(11):1463-4
pubmed: 20395285
Trends Microbiol. 2019 Feb;27(2):131-147
pubmed: 30529020
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S220-4
pubmed: 25305290
Am J Med Sci. 1959 Mar;237(3):367-403
pubmed: 13626979
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
BMC Public Health. 2011 Apr 13;11 Suppl 3:S15
pubmed: 21501432
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S310-6
pubmed: 25305303
Bioinformatics. 2015 Dec 15;31(24):3997-9
pubmed: 26315911
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Lancet. 2007 Jan 20;369(9557):229-42
pubmed: 17240290
Genome Biol. 2014 Jun 27;15(6):R76
pubmed: 24995464
Cell. 2016 Feb 25;164(5):859-71
pubmed: 26898329
Am J Trop Med Hyg. 2015 Dec;93(6):1187-93
pubmed: 26350452
BMJ Open. 2014 Jun 06;4(6):e004816
pubmed: 24907244
Sci Rep. 2017 Jan 12;7:40466
pubmed: 28079170
Sci Transl Med. 2016 Nov 23;8(366):366ra164
pubmed: 27881825
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S193-206
pubmed: 25305287
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD000371
pubmed: 22786473
Sci Rep. 2017 Oct 27;7(1):14248
pubmed: 29079756
Gut Microbes. 2015;6(2):110-9
pubmed: 25695334
World J Gastroenterol. 2014 Oct 28;20(40):14805-20
pubmed: 25356041
Nature. 2014 Nov 20;515(7527):423-6
pubmed: 25231861
Am J Trop Med Hyg. 2002 May;66(5):590-3
pubmed: 12201596
PLoS One. 2012;7(10):e48224
pubmed: 23118957
Am J Trop Med Hyg. 1999 Nov;61(5):707-13
pubmed: 10586898
Paediatr Int Child Health. 2019 Feb;39(1):41-47
pubmed: 30079818
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
Curr Opin Clin Nutr Metab Care. 2014 May;17(3):249-54
pubmed: 24613859
Gut Microbes. 2018 Jan 2;9(1):38-54
pubmed: 28767339